Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - VolitionRx (NYSEAMEX: VNRX)
Follow
NYSEAMEX:VNRX
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NYSEAMEX
VNRX
VolitionRx
Reynolds Cameron John
/
director, officer: President and CEO
11/17/2025
Buy
$0.35
20,000
$7K
2.55M
NYSEAMEX
VNRX
VolitionRx
Retter Andrew
/
officer: Chief Medical Officer
11/01/2025
Sell
$0.43
4,588
$2K
146,568
NYSEAMEX
VNRX
VolitionRx
Plummer Nicholas
/
officer: GC - Volition Diagnostics
11/01/2025
Sell
$0.43
5,647
$2K
194,084
NYSEAMEX
VNRX
VolitionRx
Rootsaert Rodney Gerard
/
officer: Secretary
11/01/2025
Sell
$0.43
3,197
$1K
137,258
NYSEAMEX
VNRX
VolitionRx
Butera Salvatore Thomas
/
officer: CEO - Volition Veterinary
11/01/2025
Sell
$0.43
4,648
$2K
321,803
NYSEAMEX
VNRX
VolitionRx
Forterre Gael
/
officer: Chief Commercial Officer
11/01/2025
Sell
$0.43
1,753
$761
153,782
NYSEAMEX
VNRX
VolitionRx
Reynolds Cameron John
/
director, officer: President and CEO
10/14/2025
Buy
$0.51
110,000
$56K
2.53M
NYSEAMEX
VNRX
VolitionRx
Reynolds Cameron John
/
director, officer: President and CEO
10/14/2025
Buy
$0.60
110,000
$66K
110,000
NYSEAMEX
VNRX
VolitionRx
Innes Guy Archibald
/
director
10/14/2025
Buy
$0.51
96,153
$49K
1.06M
NYSEAMEX
VNRX
VolitionRx
Innes Guy Archibald
/
director
10/14/2025
Buy
$0.60
96,153
$58K
96,153
NYSEAMEX
VNRX
VolitionRx
STILL TIMOTHY I
/
director
10/14/2025
Buy
$0.51
48,076
$25K
1.54M
NYSEAMEX
VNRX
VolitionRx
STILL TIMOTHY I
/
director
10/14/2025
Buy
$0.60
48,076
$29K
48,076
NYSEAMEX
VNRX
VolitionRx
Batchelor Ann-Louise
/
officer: Group Chief Marketing Officer
10/04/2025
Sell
$0.65
6,110
$4K
148,172
NYSEAMEX
VNRX
VolitionRx
Butera Salvatore Thomas
/
officer: CEO - Volition Veterinary
10/04/2025
Sell
$0.65
5,834
$4K
326,451
NYSEAMEX
VNRX
VolitionRx
Rootsaert Rodney Gerard
/
officer: Secretary
10/04/2025
Sell
$0.65
4,620
$3K
140,455
NYSEAMEX
VNRX
VolitionRx
Forterre Gael
/
officer: Chief Commercial Officer
10/04/2025
Sell
$0.65
5,389
$3K
155,535
NYSEAMEX
VNRX
VolitionRx
Plummer Nicholas
/
officer: GC - Volition Diagnostics
10/04/2025
Sell
$0.65
8,146
$5K
199,731
NYSEAMEX
VNRX
VolitionRx
Michel Gaetan
/
officer: Chief Operating Officer
10/04/2025
Sell
$0.65
12,333
$8K
256,746
NYSEAMEX
VNRX
VolitionRx
Micallef Jacob Vincent
/
officer: Chief Scientific Officer
10/04/2025
Sell
$0.65
5,850
$4K
393,089
NYSEAMEX
VNRX
VolitionRx
Rootsaert Rodney Gerard
/
officer: Secretary
09/28/2025
Sell
$0.61
4,158
$3K
145,075
NYSEAMEX
VNRX
VolitionRx
Butera Salvatore Thomas
/
officer: CEO - Volition Veterinary
09/28/2025
Sell
$0.61
5,230
$3K
332,285
NYSEAMEX
VNRX
VolitionRx
Micallef Jacob Vincent
/
officer: Chief Scientific Officer
09/28/2025
Sell
$0.61
5,568
$3K
398,939
NYSEAMEX
VNRX
VolitionRx
Batchelor Ann-Louise
/
officer: Group Chief Marketing Officer
09/28/2025
Sell
$0.61
5,604
$3K
154,282
NYSEAMEX
VNRX
VolitionRx
Michel Gaetan
/
officer: Chief Operating Officer
09/28/2025
Sell
$0.61
11,362
$7K
369,079
NYSEAMEX
VNRX
VolitionRx
Forterre Gael
/
officer: Chief Commercial Officer
09/28/2025
Sell
$0.61
5,503
$3K
160,924
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.